Minimed Group, Inc. MMED
NASDAQ
| 07/31/2026 | 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/25/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.60% | 15.61% | 14.99% | 13.11% | 10.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.60% | 15.61% | 14.99% | 13.11% | 10.89% |
| Cost of Revenue | 17.76% | 12.26% | 44.52% | 10.40% | 11.27% |
| Gross Profit | 15.67% | 18.23% | -6.84% | 15.27% | 10.59% |
| SG&A Expenses | 10.25% | 8.33% | 15.30% | 7.28% | 5.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 950.00% | 233.33% | 557.14% | 240.00% | -60.00% |
| Total Operating Expenses | 15.72% | 10.84% | 31.88% | 9.81% | 9.43% |
| Operating Income | 300.00% | 118.75% | -495.45% | 195.24% | 80.95% |
| Income Before Tax | 130.77% | 36.99% | -571.43% | 110.00% | -30.00% |
| Income Tax Expenses | 33.33% | 342.86% | -57.14% | 666.67% | 100.00% |
| Earnings from Continuing Operations | 100.00% | -10.78% | -1,485.71% | 8.70% | -39.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 100.00% | -166.67% | 0.00% | 25.00% |
| Net Income | 100.00% | -7.56% | -1,090.00% | 6.45% | -22.58% |
| EBIT | 300.00% | 118.75% | -495.45% | 195.24% | 80.95% |
| EBITDA | 21.62% | 55.71% | -181.36% | 108.51% | 57.45% |
| EPS Basic | -817.55% | -1.40% | -1,088.64% | -- | -- |
| Normalized Basic EPS | 162.24% | 179.09% | -710.75% | -- | -- |
| EPS Diluted | -820.48% | -1.72% | -1,088.64% | -- | -- |
| Normalized Diluted EPS | 162.24% | 179.09% | -710.75% | -- | -- |
| Average Basic Shares Outstanding | 11.16% | 6.07% | 0.00% | -- | -- |
| Average Diluted Shares Outstanding | 11.16% | 6.07% | 0.00% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |